United Therapeutics
Nasdaq UTHR · Silver Spring, MD
Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Immunology · Renal & urogenital · Respiratory · Women's health
United Therapeutics is a clinical trial sponsor based in Silver Spring, MD, listed as Nasdaq UTHR. It has 11 active clinical trials with 5,455 planned participants, across 8 therapeutic areas. Since 2021 it has completed 18 trials and stopped 11 early.
Trial track record · since 2021
Financials · Nasdaq UTHR
Pipeline · 11 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
5 approved drug applications with a product on the market.
Questions about United Therapeutics
United Therapeutics is lead sponsor of 11 active clinical trials on ClinicalTrials.gov, with 5,455 planned participants, in Cardiovascular, Dermatology, Genetic & rare, GI & liver and other areas. Since 2021 it has completed 18 trials and stopped 11 early.
United Therapeutics is based in Silver Spring, MD and is listed as Nasdaq UTHR. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with United Therapeutics; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-15.
Approve Suite is not affiliated with United Therapeutics.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.